
The gastrointestinal zzso hormone, zzso zzso zzso is implicated to be a zzso zzso zzso 

The aim of this study is to assess the safety, zzso and efficacy of zzso zzso to induce weight loss in obese zzso 

The study was designed as a randomized, zzso zzso zzso zzso followed by a zzso zzso zzso treatment zzso 

The study was set within a private and institutional zzso 

A total of 133 obese patients zzso mass index, zzso zzso age, zzso zzso participated in the zzso 

zzso or zzso or zzso zzso was administered as an zzso spray 20 zzso before breakfast, lunch, and dinner in conjunction with a zzso diet and zzso 

Body weight was the main outcome zzso 

The number of patients completing 12 zzso on the drug was 38 of 43 zzso 31 of 44 zzso and 12 of 46 zzso for zzso 200 zzso three times a day zzso and 600 zzso zzso zzso In the 600 zzso zzso group, 27 of 46 zzso patients discontinued due to zzso and zzso Among all zzso patients who took at least one drug dose and had a zzso zzso the mean body weight change from baseline was zzso zzso and zzso zzso for zzso 200 and 600 zzso zzso The least squares mean difference zzso confidence zzso between zzso and 200 zzso was zzso zzso zzso zzso zzso zzso zzso A difference of zzso zzso was zzso No meaningful zzso can be drawn from the few patients who completed the study on 600 zzso 

zzso zzso as administered at these intervention doses and zzso timing is not zzso in inducing weight loss in obese patients after 12 zzso of zzso 

